Based on the Cyfuse Biomedical K.K. stock forecast from 0 analysts, the average analyst target price for Cyfuse Biomedical K.K. is not available over the next 12 months. Cyfuse Biomedical K.K.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Cyfuse Biomedical K.K. is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, Cyfuse Biomedical K.K.’s stock price was JPY 441.00. Cyfuse Biomedical K.K.’s stock price has changed by -2.00% over the past week, -7.93% over the past month and -40.32% over the last year.
No recent analyst target price found for Cyfuse Biomedical K.K.
No recent average analyst rating found for Cyfuse Biomedical K.K.
Company Overview Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan. Read Less
Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also of...Read More
Frequently Asked Questions About Cyfuse Biomedical K.K. (4892:TSE) Stock
Stock Target Advisor's fundamental analysis for Cyfuse Biomedical K.K.'s stock is Bearish.
Unfortunately we do not have enough data on 4892:TSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4892:TSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4892:TSE's stock to indicate if its overvalued.
The last closing price of 4892:TSE's stock was JPY 441.00.
The most recent market capitalization for 4892:TSE is JPY 3.94B.
Unfortunately we do not have enough analyst data on 4892:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Cyfuse Biomedical K.K.'s stock.
As per our most recent records Cyfuse Biomedical K.K. has 21 Employees.
Cyfuse Biomedical K.K.'s registered address is Sumitomo Fudosan Mita Twin Building, Tokyo, Japan, 108-6301.
You can get more information about it from Cyfuse Biomedical K.K.'s website at https://www.cyfusebio.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Cyfuse Biomedical K.K. (4892:TSE) Stock
Stock Target Advisor's fundamental analysis for Cyfuse Biomedical K.K.'s stock is Bearish.
Unfortunately we do not have enough data on 4892:TSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4892:TSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4892:TSE's stock to indicate if its overvalued.
The last closing price of 4892:TSE's stock was JPY 441.00.
The most recent market capitalization for 4892:TSE is JPY 3.94B.
Unfortunately we do not have enough analyst data on 4892:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Cyfuse Biomedical K.K.'s stock.
As per our most recent records Cyfuse Biomedical K.K. has 21 Employees.
Cyfuse Biomedical K.K.'s registered address is Sumitomo Fudosan Mita Twin Building, Tokyo, Japan, 108-6301.
You can get more information about it from Cyfuse Biomedical K.K.'s website at https://www.cyfusebio.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4892:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
